Latest Insider Transactions at 180 Life Sciences Corp. (ATNF)
This section provides a real-time view of insider transactions for 180 Life Sciences Corp. (ATNF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 180 Life Sciences Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 180 Life Sciences Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2025
|
Ryan Lewis Smith Director |
BUY
Bona fide gift
|
Indirect |
16,718
+50.0%
|
-
|
|
Dec 01
2025
|
Ryan Lewis Smith Director |
SELL
Bona fide gift
|
Direct |
16,718
-100.0%
|
-
|
|
Nov 14
2025
|
Mc Andrew Rudisill Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
370,000
+47.12%
|
-
|
|
Nov 14
2025
|
Mc Andrew Rudisill Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
410,865
-37.58%
|
-
|
|
Nov 14
2025
|
Ryan Lewis Smith Director |
BUY
Bona fide gift
|
Indirect |
267,137
+50.0%
|
-
|
|
Nov 14
2025
|
Ryan Lewis Smith Director |
SELL
Bona fide gift
|
Direct |
267,137
-36.71%
|
-
|
|
Nov 14
2025
|
Andrew P Suckling Director |
BUY
Bona fide gift
|
Indirect |
149,020
+50.0%
|
-
|
|
Nov 14
2025
|
Andrew P Suckling Director |
SELL
Bona fide gift
|
Direct |
149,020
-50.0%
|
-
|
|
Nov 14
2025
|
Crystal Jane Heter Director |
BUY
Bona fide gift
|
Indirect |
182,742
+50.0%
|
-
|
|
Nov 14
2025
|
Crystal Jane Heter Director |
SELL
Bona fide gift
|
Direct |
182,742
-50.0%
|
-
|
|
Nov 14
2025
|
Jason Griffin New Director |
BUY
Bona fide gift
|
Indirect |
218,456
+50.0%
|
-
|
|
Nov 14
2025
|
Jason Griffin New Director |
SELL
Bona fide gift
|
Direct |
218,456
-30.74%
|
-
|
|
Nov 12
2025
|
John Tazewell Saunders Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,447
-21.45%
|
-
|
|
Nov 12
2025
|
John Tazewell Saunders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109,312
+50.0%
|
-
|
|
Nov 12
2025
|
Mc Andrew Rudisill Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
271,635
-19.9%
|
-
|
|
Nov 12
2025
|
Mc Andrew Rudisill Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,365,000
+50.0%
|
-
|
|
Nov 12
2025
|
Ryan Lewis Smith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
176,613
-19.53%
|
-
|
|
Nov 12
2025
|
Ryan Lewis Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
887,500
+49.53%
|
-
|
|
Nov 12
2025
|
Andrew P Suckling Director |
SELL
Payment of exercise price or tax liability
|
Direct |
175,854
-27.07%
|
-
|
|
Nov 12
2025
|
Andrew P Suckling Director |
BUY
Grant, award, or other acquisition
|
Direct |
649,748
+50.0%
|
-
|
|
Nov 12
2025
|
Crystal Jane Heter Director |
SELL
Payment of exercise price or tax liability
|
Direct |
142,132
-21.87%
|
-
|
|
Nov 12
2025
|
Crystal Jane Heter Director |
BUY
Grant, award, or other acquisition
|
Direct |
649,748
+50.0%
|
-
|
|
Nov 12
2025
|
Jason Griffin New Director |
SELL
Payment of exercise price or tax liability
|
Direct |
257,794
-26.6%
|
-
|
|
Nov 12
2025
|
Jason Griffin New Director |
BUY
Grant, award, or other acquisition
|
Direct |
952,500
+50.0%
|
-
|
|
Aug 21
2025
|
Blair Jordan Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
200,000
-100.0%
|
-
|
|
Aug 11
2025
|
Elray Resources, Inc. |
SELL
Open market or private sale
|
Direct |
405,148
-23.48%
|
$1,215,444
$3.17 P/Share
|
|
Aug 08
2025
|
Elray Resources, Inc. |
SELL
Open market or private sale
|
Direct |
777,595
-31.07%
|
$2,332,785
$3.18 P/Share
|
|
Aug 07
2025
|
Elray Resources, Inc. |
SELL
Open market or private sale
|
Direct |
135,257
-5.13%
|
$405,771
$3.56 P/Share
|
|
Jul 27
2025
|
Elray Resources, Inc. |
SELL
Open market or private sale
|
Direct |
1,680,000
-38.91%
|
$5,040,000
$3.0 P/Share
|
|
Jul 27
2025
|
Elray Resources, Inc. |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,000,000
+40.99%
|
$3,000,000
$1.68 P/Share
|
|
Jul 07
2025
|
Blair Jordan Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
160,000
+32.82%
|
-
|
|
Jul 07
2025
|
Blair Jordan Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
160,000
-100.0%
|
-
|
|
Jun 17
2025
|
Lawrence Steinman Director |
BUY
Grant, award, or other acquisition
|
Direct |
48,198
+29.4%
|
-
|
|
Jun 17
2025
|
Stephen H Shoemaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
72,297
+34.49%
|
-
|
|
Jun 17
2025
|
Ryan Lewis Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
109,541
+38.56%
|
-
|
|
Jun 17
2025
|
Eric R Van Lent Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,763
+50.0%
|
-
|
|
Jun 17
2025
|
Blair Jordan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
179,646
+50.0%
|
-
|
|
Apr 28
2025
|
Blair Jordan Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
1,318,000
+50.0%
|
-
|
|
Mar 27
2025
|
Elray Resources, Inc. |
BUY
Conversion of derivative security
|
Direct |
1,318,000
+50.0%
|
-
|
|
Feb 21
2025
|
Blair Jordan Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
200,000
+50.0%
|
-
|
|
Feb 20
2025
|
Stephen H Shoemaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+50.0%
|
-
|
|
Feb 20
2025
|
Blair Jordan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+50.0%
|
-
|
|
Feb 20
2025
|
Jay Lawrence Goodman Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+50.0%
|
-
|
|
Feb 20
2025
|
Lawrence Steinman Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+49.04%
|
-
|
|
Feb 20
2025
|
Ryan Lewis Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+50.0%
|
-
|
|
Feb 05
2025
|
Blair Jordan Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
43,166
+50.0%
|
-
|
|
Dec 28
2023
|
Marc Feldmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
135,377
+35.05%
|
-
|
|
Dec 15
2023
|
James N. Woody Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+27.21%
|
$0
$0.19 P/Share
|
|
Dec 15
2023
|
Marc Feldmann Director |
SELL
Open market or private sale
|
Direct |
25,000
-17.79%
|
$0
$0.19 P/Share
|
|
Sep 04
2023
|
Russell T Ray Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,455
+46.78%
|
$21,455
$1.36 P/Share
|